Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;55(9):4394-7.
doi: 10.1128/AAC.00833-10. Epub 2011 Jun 27.

In vitro spectrum of activity of finafloxacin, a novel, pH-activated fluoroquinolone, under standard and acidic conditions

Affiliations

In vitro spectrum of activity of finafloxacin, a novel, pH-activated fluoroquinolone, under standard and acidic conditions

Will Stubbings et al. Antimicrob Agents Chemother. 2011 Sep.

Abstract

Finafloxacin is a novel fluoroquinolone that exhibits enhanced antibacterial activity under acidic conditions. The aim of this study was to define the in vitro pH-activity relationship. Finafloxacin exhibited optimal antibacterial activity between pH 5.0 and 6.0 at which MICs were 4- to 8-fold lower than those determined at neutral pH. These observations were then confirmed against a larger collection of bacteria. These data suggest that finafloxacin could potentially offer a therapeutic advantage within acidic foci of infection.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
MICs of finafloxacin, ciprofloxacin, and levofloxacin at pH values of 7.4 and below. Key: ▾, finafloxacin; □, ciprofloxacin; ▵, levofloxacin.

References

    1. Byerly T. C. 1953. Handbook of biological data. Science 118:3.
    1. Clinical and Laboratory Standards Institute 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed Approved standard M07–A7. Clinical and Laboratory Standards Institute, Wayne, PA
    1. Clinical and Laboratory Standards Institute 2007. Performance standards for antimicrobial susceptibility testing; 17th informational supplement. Document M100–S17. Clinical and Laboratory Standards Institute, Wayne, PA
    1. Dalhoff A., Schubert S., Ullmann U. 2005. Effect of pH on the in vitro activity of and propensity for emergence of resistance to fluoroquinolones, macrolides, and a ketolide. Infection 33(Suppl. 2):36–43 - PubMed
    1. Dalhoff A., Stubbings W., Schubert S. 2011. Comparative in vitro activities of the novel antibacterial finafloxacin against selected Gram-positive and Gram-negative bacteria tested in Mueller-Hinton broth and synthetic urine. Antimicrob. Agents Chemother. 55:1814–1818 - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources